Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 5/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 3/20 | 0.38 |
| ▸ | RXRB | P28702 | 3/20 | 0.38 |
| ▸ | RXRG | P48443 | 2/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.36 |
| ▸ | FEN1 | P39748 | 3/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | TEK | Q02763 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26548847 | 0.94 | TDO2 (0.45) | KDM1ATDP1IDO1TDO2RXRA | |
| SCHEMBL26548858 | 0.94 | KDM1A (0.47) | KDM1ATDP1IDO1TDO2RXRA | |
| SCHEMBL26548856 | 0.91 | TDP1 (0.47) | KDM1ATDP1IDO1TDO2HSD17B1 | |
| SCHEMBL26548840 | 0.91 | TDP1 (0.44) | KDM1ATDP1IDO1TDO2MAOB | |
| SCHEMBL26548692 | 0.91 | KDM1A (0.42) | KDM1ATDP1HSD17B1HSD17B2MAOB | |
| SCHEMBL26548721 | 0.90 | S1PR1 (0.44) | KDM1ATDP1IDO1TDO2MAOB | |
| SCHEMBL26548179 | 0.90 | CYP11B1 (0.43) | KDM1ATDP1HSD17B1HSD17B2MAOB | |
| SCHEMBL26548363 | 0.89 | IDO1 (0.46) | KDM1ATDP1IDO1TDO2HSD17B1 | |
| SCHEMBL26548860 | 0.89 | KDM1A (0.43) | KDM1ATDP1IDO1TDO2RXRA | |
| SCHEMBL26548855 | 0.89 | TDO2 (0.42) | KDM1ATDP1IDO1TDO2RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | KDM1A 114/4885TDP1 924/4885IDO1 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.